000 | 01041 a2200301 4500 | ||
---|---|---|---|
005 | 20250515194116.0 | ||
264 | 0 | _c20091207 | |
008 | 200912s 0 0 eng d | ||
022 | _a1474-4465 | ||
024 | 7 |
_a10.1016/S1474-4422(09)70288-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStefanova, Nadia | |
245 | 0 | 0 |
_aMultiple system atrophy: an update. _h[electronic resource] |
260 |
_bThe Lancet. Neurology _cDec 2009 |
||
300 |
_a1172-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMultiple System Atrophy _xepidemiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRiluzole _xtherapeutic use |
650 | 0 | 4 |
_aalpha-Synuclein _xgenetics |
700 | 1 | _aBücke, Philipp | |
700 | 1 | _aDuerr, Susanne | |
700 | 1 | _aWenning, Gregor Karl | |
773 | 0 |
_tThe Lancet. Neurology _gvol. 8 _gno. 12 _gp. 1172-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1474-4422(09)70288-1 _zAvailable from publisher's website |
999 |
_c19296277 _d19296277 |